Islet cells

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Pancreatic Adenocarcinoma Gene Environment Risk Study

University of Minnesota Transplant Registry

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

Islet Transplantation in Type 1 Diabetic Kidney Allograft

Immune Monitoring and Assay Development in Organ Transplant Recipients

Islet Transplantation in Patients With "Brittle" Type I Diabetes

COsegregation of VARiants in Panel of Genes

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

The Cancer of the Pancreas Screening-5 CAPS5)Study

Integrated Cancer Repository for Cancer Research

Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Pancreatic Surgical Database

Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

Analysis of Graft Function Following Autologous Islet Transplantation

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

EUS-guided RFA for Pancreatic Neoplasms

BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Registry of Endocrine Tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube)

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer

Regulation of Endogenous Glucose Production by Central KATP Channels

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

New Biomarkers in Pancreatic Cancer Using EXPEL Concept

Registry of Pancreatic Disease

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Lidocaine Infusion in Pancreatic Cancer

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients

Registry of Subjects at Risk of Pancreatic Cancer

PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Prospective Monocentric Clinical-biological Database

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

Protocol ITANET - Registry

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Kidney Precision Medicine Project

Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms

D2 vs D3 Lymph Node Dissection for Left Colon Cancer

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

SERum-bank for PANcreatic Cancer

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)

Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

Advanced Therapies for Liver Metastases

The T1D Exchange Registry

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

TumorGlow Intraoperative Molecular Imaging (IMI)

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

EUS-CPN With and Without Bupivacaine

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

DETERMINE: Detemir vs NPH

Evaluation of Resection Techniques for Pancreatic Tumors

Monitoring and Managing Glucose Levels in People With Pancreatic Cancer

Prognostic Factors in Periampullary Tumors and Cysts

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Pharmacotyping of Pancreatic Patient-derived Organoids

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer

Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers

TT-702 in Patients With Advanced Solid Tumours.

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Improvement in Glycemic Response After Bariatric Surgery

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

The Effects of the CF Carrier State on the Kidneys and Pancreas

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)

Microbiota and Pancreatic Cancer Cachexia

Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T

ExoLuminate Study for Early Detection of Pancreatic Cancer

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

REVOLUTION Surgery (REVOLUTION Surgery)

Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

Familial Pancreatic Cancer PROPHilation Program in Italy

Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples

Collection of Circulating Biomarkers in Pancreatic Cancer

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

PAncreatic Disease Cohort of TOuLouse

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas

Management of Traumatic Pancreas Transection

A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

PRE-ISPY Phase I/II Oncology Platform Program

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Patient Recorded Indexing Measurements

A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

Determining Individualized Cancer Therapy in Pancreatic Cancer

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes

SGLTi, Hepatic Glucose Production and Ketogenesis

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Intranasal Insulin for Treatment of Alcohol Use Disorder

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy

Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

Shwachman Diamond Syndrome Registry and Study

The Pancreatic Enzymes After Gastrectomy Trial

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

COMMETS- Combination MCI Metabolic Syndrome

A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer

Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)

Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer

Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy

Early Pancreatic Stent Placement for Preventing PEP

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

Promoting CT Engagement for Pancreatic Cancer With App

POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis

Australian Genomics Of Chronic Allograft Dysfunction Study

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Pancreatic Cancer Screening in a Population at High Risk

YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

Italian Registry of Minimally Invasive Pancreatic Surgery

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

Namodenoson Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Detection Consortium

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

Regional Lipolysis Insulin Regulation

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

The Use of Islet Organoids in the Treatment of Pancreatic Surgery-related Diabetes

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer

A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)

Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms

Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

CEB-01 in Locally Resectable Pancreatic Cancer

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

Adebrelimab and Chidamide for Pancreatic Cancer

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.

Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer

ImmunoPET Imaging of Pancreatic Cancer

Pan-tumor MRD Study

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

RCT Glargine vs NPH for Treatment of DM in Pregnancy

AI-Assisted Non-Contrast CT for Multi-Cancer Screening

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

External Pancreatic Stent in Pancreaticojejunostomy

Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes

Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler

PAN Alimentary Cancer Exhaled Breath Analysis

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

GDM: Insulin with or Without Metformin?

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Maternal Abdominal Morphology Assessment

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Using Tumor Models to Determine Treatments

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.

Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Automated Insulin for Management of Intrapartum Glycemia

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients

A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Natural Course and Therapeutic Effect of Chronic Pancreatitis

An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer

Hybrid Closed-Loop System in LADA Patients: A Randomized Trial

A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Imatinib and Trametinib for KRAS-mutated Solid Tumor

Adjuvant Pancreatic Therapy Guided by MRD

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Clinical Application of FL-091 Radionuclide Imaging in Diagnosis and Staging of Malignant Tumors

Robotic vs Open Pancreatoduodenectomy

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

Laparoscopic Pancreaticoduodenectomy

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

RCT Comparing Accuracy Among Franseen, Forward-bevel Westcott, and Fork-tip EUS-FNB Needle in Diagnosis of Solid Pancreatic Lesions

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX

MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer

PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

CtDNA-guided Maintenance Therapy in Pancreatic Cancer

A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Utility of ctDNA in Early Switch of First-line Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Exploring Photon-Counting CT for Enhanced Target Delineation and Dose Accuracy in Personalized Radiotherapy - ANTHEM

A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

The KN510713 Study in Combination With mFOLFIRINOX

FTT PET/CT in Pancreatic Neuroendocrine Tumors

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs

Immunoparalysis After Pancreaticoduodenectomy

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Identification of a Score for the Assessment of Intrapancreatic Fat

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors

Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas

EXoPERT EMERALD Clinical Study

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer

HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

Surgery for Locally Unresectable Pancreatic Cancer

The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa

Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

PULSAR in Systemic Therapy for Pancreatic Cancer

Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions

Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents

To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

Increasing Germline Genetic Testing for Patients With Cancer

Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy

A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer

A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Intratumoral N17350 in Advanced Solid Tumors

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

FAPi PET in Pancreatic Ductal Adenocarcinoma

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)

Prevention of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy by Preoperative Radiotherapy : a Phase 2 Trial

Opioid-free Anesthesia as an Alternative to General Anesthesia in Patients Undergoing Laparoscopic Peripheral Pancreatic Resection

An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound

Delayed Gastric Emptying After Pancreatic Surgery

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.

Comparing the Efficacy and Safety of Holmium Laser Lithotripsy Versus Electrohydraulic Lithotripsy for the Treatment of Difficult Choledocholithiasis and Pancreatic Duct Stones

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Production of Stem Cells for the Generation of Pancreatic Cells

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Evaluation of the Perfusion of the Pancreatic Remnant With Indocyanine Green and Its Impact on the Reduction of Pancreatic Fistula After Pancreaticoduodenectomy

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms

Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography

PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Nutrition Intervention for Pancreatic Cancer

Perioperative Pharmacokinetic/Pharmacodynamic Target Attainment of Piperacillin During Major Hepatic and Pancreatic Surgery

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.

Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC

Whole-life Investigation of Lishui Longevity

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Preliminary Trial of SNA014 for Pancreatic Cancer

Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical Trial

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma

Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement

Evaluation of XYA02 in Patients With Advanced Solid Tumors

A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

Phosphate in Acute Pancreatitis

Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer

IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

Internal Organ and Musculoskeletal Assessment in Hypothyroidism (HYPOMORPH)

Exercise to Improve Outcomes in Pancreatic Cancer

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)